We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ABCAP:AQUISEUABC arbitrage SA Analysis

Data as of 2026-06-22 - not real-time

₹391.95

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Aditya Birla Capital is trading at INR 391.95, comfortably above its 20‑day (360.18), 50‑day (353.77) and 200‑day (334.42) moving averages, indicating a strong bullish trend. The MACD is bullish (line 7.19 above signal 3.86) and volume is increasing, while the RSI at 68 suggests the stock is approaching overbought territory near its resistance of INR 392.90. The market sentiment is extremely positive, reflected by a Fear‑Greed Index of 90.18 (Extreme Greed).
Fundamentally, the company posted 7.7% revenue growth with solid gross (27.7%) and operating margins (13.7%), but its balance sheet is strained by a massive debt load (₹1.81 trillion) and a debt‑to‑equity ratio of 491.7, coupled with negative operating cash flow. The current PE of 27.5 is above the industry average (16.9), yet the forward PE of 16.0 aligns with peers, supporting a target price around INR 412. The consensus of 12 analysts rates the stock as a "strong buy" despite the lack of dividend.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just below resistance at INR 392.90
  • RSI approaching overbought levels (68)
  • Strong bullish MACD and rising volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus of "strong buy" with target median price INR 412.5
  • Forward PE of 15.99 indicating valuation improvement
  • Continued bullish technical momentum and increasing market optimism

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • High leverage (debt‑to‑equity > 490) and negative operating cash flow
  • Diversified financial services platform with stable revenue growth
  • Potential upside limited to ~5% based on upside/downside estimate

Key Metrics & Analysis

Financial Health

Revenue Growth7.70%
Profit Margin11.65%
P/E Ratio27.5
ROE11.18%
ROA1.26%
Debt/Equity491.75
P/B Ratio3.0
Op. Cash Flow₹-365441187840
Industry P/E16.9

Technical Analysis

TrendBullish
RSI68.0
Support₹334.80
Resistance₹392.90
MA 20₹360.18
MA 50₹353.77
MA 200₹334.42
MACDBullish
VolumeIncreasing
Fear & Greed Index90.18

Valuation

Target Price₹411.42
Upside/Downside4.97%
GradeFair
TypeBlend

Risk Assessment

Beta0.77
Volatility35.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.